Results 241 to 246 of about 34,802 (246)

A grey zone in canakinumab tapering: dose reduction or interval prolongation?

Rheumatology
Çisem Yıldız, Sevcan A Bakkaloğlu
openaire   +3 more sources

Flare prediction after tapering the dose of tumour necrosis factor inhibitors in patients with axial spondyloarthritis: a nationwide cohort study

Rheumatology
Jina Yeo, Ju Yeon Kim, Jin Kyun Park
exaly  

Continuing versus tapering low-dose glucocorticoids in patients with rheumatoid arthritis and systemic lupus erythematosus in states of low disease activity or remission: A systematic review and meta-analysis of randomised trials

Seminars in Arthritis and Rheumatism
Andriko Palmowski, Anne Pankow, Sabrina Mai Nielsen   +2 more
exaly  

Risk of relapse during tapering of antipsychotic medication after a first psychotic episode: association with D2 receptor affinity but not with tapering speed

World Psychiatry
Nico Van Beveren, Martijn Kikkert, Sanne Koops   +2 more
exaly  

Growing evidence supports low-dose ketamine infusions to facilitate opioid tapering

Regional Anesthesia & Pain Medicine
Taif Mukhdomi, Bennett Andrassy, Marcus Harris   +2 more
openaire   +2 more sources

More than a dose taper: context and prediction in antipsychotic withdrawal for intellectual disability

Evidence Based Nursing
openaire   +2 more sources